The global intravenous (IV) hydration therapy market size reached US$ 2.34 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2028, exhibiting a growth rate (CAGR) of 7.89% during 2023-2028. The growing popularity of anti-aging beauty treatments among women, rising rates of hospitalization due to the increasing prevalence of chronic diseases, and technological advancements in the healthcare industry are some of the major factors propelling the market.
|Market Size in 2022
||US$ 2.34 Billion
|Market Forecast in 2028
||US$ 3.7 Billion
|Market Growth Rate (2023-2028)
Intravenous (IV) hydration therapy refers to the process of administering fluids, medications, hormones, and nutrients directly into the bloodstream of patients. It is performed by trained professionals, including doctors, surgeons, and nurses, via the insertion of a small catheter or needle into a vein through which fluids are delivered. It is considered an effective method of addressing dehydration caused by illness, excessive sweating, vomiting, diarrhea, or inadequate fluid intake. It allows rapid absorption and distribution of medications throughout the body. Furthermore, it helps reduce symptoms associated with dehydration, such as fatigue, dizziness, headaches, and muscle cramps.
The rising demand for IV hydration therapy, as it is convenient and effective in administering various medications into the bloodstream, is impelling the growth of the market. Besides this, rising construction of hospitals, nursing homes, and clinics to provide quality healthcare services to patients is propelling the market growth. In addition, the growing demand for energy boosters and immunity boosters among athletes and fitness enthusiasts to improve their performance and maintain energy levels is offering a favorable market outlook. Apart from this, the increasing awareness about the beneficial aspects of providing hydration to the skin is supporting the growth of the market. Additionally, the rising utilization of IV hydration therapy for delivering medications to patients suffering from rheumatoid arthritis, Crohn's disease, osteoporosis, systemic lupus, gout, and psoriasis is strengthening the growth of the market.
Intravenous (IV) Hydration Therapy Market Trends/Drivers:
Rising adoption of beauty treatments are stimulating market growth
At present, there is an increase in the demand for various beauty therapies due to the rising number of working women who are investing in beauty services. These women are also focusing on incorporating holistic anti-aging products and therapies in their skincare regime to prevent the early signs of aging. They are utilizing intravenous (IV) hydration therapies to provide an adequate amount of hydration to the skin and prevent the formation of dry and chapped patches. Besides this, IV hydration therapy provides a healthy glow to the skin and enhances the overall skin texture. It also helps flush out toxins from the body and prevent ultraviolet (UV) damage.
Technological advancements in the healthcare industry augmenting market growth
At present, there is a rise in the integration of technologically advanced medical equipment to enhance the overall healthcare services. Efficient medical devices, such as smart infusion pumps or smart IV pumps, are readily replacing manually or mechanically operated infusion devices in various healthcare facilities to improve treatment and diagnostic procedures. They are also maintaining the accurate delivery of various essential fluids, hormones, antibiotics, chemotherapy drugs, pain relievers, and medications to improve patient health. They deliver fluids based on the requirements of patients. They are safe, reliable, and easy-to-use devices that present a flexible choice to fulfill clinical needs. Furthermore, they can support all modes of therapy, patient types, and clinical applications.
Rising rate of hospitalization is catalyzing the demand for IV hydration therapy
Presently, increasing rates of hospitalization around the world represent one of the key factors catalyzing the demand for IV hydration therapy. The occurrence of numerous health complications, including heart attacks, strokes, kidney failure, gallstones, liver cirrhosis, and insulin resistance, due to the adoption of sedentary lifestyle habits and the consumption of unhealthy diets. Apart from this, the growing cases of cancer among individuals due to the excessive smoking and consumption of alcohol is increasing the utilization of IV hydration therapy in hospitals. Furthermore, as IV hydrating therapy is considered a convenient and effective method to administer various hormones, medications, electrolytes, and fluids through the bloodstream into the body, its demand is increasing in hospitals.
Intravenous (IV) Hydration Therapy Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global intravenous (IV) hydration therapy market report, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on component, service, and end user.
Breakup by Component:
Medicated dominates the intravenous (IV) hydration therapy market
The report has provided a detailed breakup and analysis of the intravenous (IV) hydration therapy market based on the component. This includes medicated and non-medicated. According to the report, medicated represented the largest segment.
Intravenous therapy for medical purposes involves administering fluids, medications, and vitamins directly into the bloodstream of patients who are suffering from various medical conditions, including nutritional deficiencies. Its primary purpose is to replenish deficient substances in the body which occur due to underlying medical conditions. It also helps administer medications into the bloodstream of individuals who are incapable of taking them orally. Furthermore, it is employed to provide an urgent dose of antibiotics to patients dealing with a severe infection or sepsis.
Breakup by Service:
- Immune Boosters
- Energy Boosters
- Skin Care
Energy boosters hold the largest market share
A detailed breakup and analysis of the intravenous (IV) hydration therapy market based on the service has also been provided in the report. This includes immune boosters, energy boosters, skin care, migraine, and others. According to the report, energy boosters accounted for the largest market share.
Intravenous fluids containing electrolytes, vitamins, and minerals are often used as energy boosters and administered to increase energy levels and minimize fatigue in the body. They also contain various antioxidants, which help combat feelings of low energy and mood swings. They help reduce toxins, improve blood flow, and increase alertness.
Migraines are often treated by employing intravenous hydration therapy by administering electrolytes and vitamins directly into the bloodstream. Intravenous hydration therapy provides effective relief from headaches and prevents dehydration, which is considered a major cause of migraine.
Intravenous hydration therapy plays a quintessential role in providing necessary hydration to the skin for treating chapped, flaky, and dry patches.
Breakup by End User:
- Hospitals and Clinics
- Wellness Centers and Spas
- Home Healthcare
Hospitals and clinics account for the majority of the market share
A detailed breakup and analysis of the intravenous (IV) hydration therapy market based on the end user has also been provided in the report. This includes hospitals and clinics, wellness centers and spas, home healthcare, and others. According to the report, hospitals and clinics accounted for the largest market share.
Hospitals and clinics require intravenous hydration therapy to treat patients dealing with numerous health complications. They are essential for providing nutrients and hydration to individuals who are suffering from severe nausea and infections. They also administer intravenous fluids into the bloodstream of patients to prevent or correct problems with fluid and electrolyte status when oral administration is not possible or is impaired.
Wellness centers and spas utilize intravenous hydration therapy for the purpose of drip spas, wherein essential nutrients are administered into the body via the bloodstream. They also provide intravenous fluids to improve skin treatments in individuals. They employ intravenous hydration therapy to provide instant hydration to the skin and enhance the skin texture.
Breakup by Region:
- North America
- United Kingdom
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa
North America exhibits a clear dominance, accounting for the largest intravenous (IV) hydration therapy market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
North America held the biggest market share since the region has a well medical infrastructure and an increased number of patients willing to spend on overall wellness and health management. Besides this, the rising occurrence of various chronic disorders, along with the increasing rates of hospitalization, is propelling the growth of the market. Apart from this, the growing awareness about the beneficial properties of energy and immune boosters to improve overall health conditions is catalyzing the demand for intravenous hydration therapy in the region.
Asia Pacific is estimated to expand further due to the rising construction of hospitals and clinics, along with rising investments by governing agencies to improve healthcare conditions.
Key market players are experiencing a rise in the demand for intravenous (IV) hydration therapy devices due to increasing rates of hospitalization, along with the growing demand for energy boosters among fitness enthusiasts and athletes. They are also developing smart infusion technology wherein clinical decision support tools are integrated into the medication administration process. Leading companies are investing in manufacturing efficient infusion pumps with alerts or alarms, keep-vein open (KVO) facilities, and pressure control. They are also collaborating with hospitals, nursing homes, and clinics to provide them with reasonably priced smart intravenous infusion dosing systems and contribute to improving healthcare services. Top companies are focusing on mergers and partnerships with other firms to expand their production rates and increase their sales.
The report has provided a comprehensive analysis of the competitive landscape in the global intravenous (IV) hydration therapy market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
- Amanta Healthcare Ltd.
- B. Braun Medical Inc.
- Baxter International Inc.
- Cryojuvenate UK Ltd.
- Drip Hydration
- JW Life Science
- NexGen Health
- In June 2023, B. Braun Medical Inc. announced the launch of its next generation of infusion management software, named DoseTrac Enterprise Infusion Management Software, which will enable organizations to combine real-time views and retrospective reporting features to efficiently understand their infusion pump fleet.
- In July 2019, Baxter International Inc. announced the U.S. Food and Drug Administration (FDA) approval for Myxredlin, which is the first and only ready-to-use insulin for intravenous infusion.
- In March 2023, NexGen Health announced the launch of Mirth Cloud Connect, a cloud-based solution that offers interoperability as a managed solution.
Intravenous (IV) Hydration Therapy Market Report Scope:
|Base Year of the Analysis
| Historical Period
|Scope of the Report
||Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
- End User
||Immune Boosters, Energy Boosters, Skin Care, Migraine, Others
|End Users Covered
||Hospitals and Clinics, Wellness Centers and Spas, Home Healthcare, Others
||Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Amanta Healthcare Ltd., B. Braun Medical Inc., Baxter International Inc., Cryojuvenate UK Ltd., Drip Hydration, JW Life Science, NexGen Health, etc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report:
- How has the global intravenous (IV) hydration therapy market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global intravenous (IV) hydration therapy market?
- What is the impact of each driver, restraint, and opportunity on the global intravenous (IV) hydration therapy market?
- What are the key regional markets?
- Which countries represent the most attractive global intravenous (IV) hydration therapy market?
- What is the breakup of the market based on the component?
- Which is the most attractive component in the global intravenous (IV) hydration therapy market?
- What is the breakup of the market based on the service?
- Which is the most attractive service in the global intravenous (IV) hydration therapy market?
- What is the breakup of the market based on the end user?
- Which is the most attractive end user in the global intravenous (IV) hydration therapy market?
- What is the competitive structure of the global intravenous (IV) hydration therapy market?
- Who are the key players/companies in the global intravenous (IV) hydration therapy market?
Key Benefits for Stakeholders:
- IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the intravenous (IV) hydration therapy market from 2017-2028.
- The research study provides the latest information on the market drivers, challenges, and opportunities in the global intravenous (IV) hydration therapy market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the intravenous (IV) hydration therapy industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.